CELLINK AB announces the completion of the offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an overall amount of SEK 3.0 billion 03/15/2021 Company news Read press release
03/15/2021 | 3d bioprinting CELLINK launches the BIO MDX Series, a scaled-up revolution in biomedical manufacturing
03/15/2021 | Company news CELLINK AB announces the completion of the offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an overall amount of SEK 3.0 billion
03/15/2021 | Company news CELLINK has entered into an agreement to acquire MatTek, the global leader in in-vitro technology and alternative drug testing models
02/15/2021 | Company news CELLINK has entered into an agreement to acquire the advanced robotics and diagnostics automation company Ginolis
01/28/2021 | Company news CELLINK launches UP.SIGHT, a rapid, all-in-one imager and single-cell dispenser that offers double assurance of clonality